353 related articles for article (PubMed ID: 35163633)
21. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
[TBL] [Abstract][Full Text] [Related]
22. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
23. Brain tumor vessels-a barrier for drug delivery.
Hempel C; Johnsen KB; Kostrikov S; Hamerlik P; Andresen TL
Cancer Metastasis Rev; 2020 Sep; 39(3):959-968. PubMed ID: 32488404
[TBL] [Abstract][Full Text] [Related]
24. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Delivery to Central Nervous System.
Kunigelis KE; Vogelbaum MA
Neurosurg Clin N Am; 2021 Apr; 32(2):291-303. PubMed ID: 33781509
[TBL] [Abstract][Full Text] [Related]
26. Surgical Adjuncts for Glioblastoma.
Hartnett S; Kroll D; Vogelbaum MA
Neurosurg Clin N Am; 2021 Jan; 32(1):83-91. PubMed ID: 33223029
[TBL] [Abstract][Full Text] [Related]
27. Drug delivery systems for brain tumor therapy.
Rautioa J; Chikhale PJ
Curr Pharm Des; 2004; 10(12):1341-53. PubMed ID: 15134485
[TBL] [Abstract][Full Text] [Related]
28. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.
Fana M; Gallien J; Srinageshwar B; Dunbar GL; Rossignol J
Int J Nanomedicine; 2020; 15():2789-2808. PubMed ID: 32368055
[TBL] [Abstract][Full Text] [Related]
29. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme.
Jena L; McErlean E; McCarthy H
Drug Deliv Transl Res; 2020 Apr; 10(2):304-318. PubMed ID: 31728942
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanisms of Drug Resistance in Glioblastoma.
Dymova MA; Kuligina EV; Richter VA
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203727
[TBL] [Abstract][Full Text] [Related]
31. Recent developments in drug delivery strategies for targeting DNA damage response in glioblastoma.
Morás AM; Henn JG; Steffens Reinhardt L; Lenz G; Moura DJ
Life Sci; 2021 Dec; 287():120128. PubMed ID: 34774874
[TBL] [Abstract][Full Text] [Related]
32. Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma.
Pena ES; Graham-Gurysh EG; Bachelder EM; Ainslie KM
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884965
[TBL] [Abstract][Full Text] [Related]
33. Strategies to Improve Drug Delivery Across the Blood-Brain Barrier for Glioblastoma.
Narsinh KH; Perez E; Haddad AF; Young JS; Savastano L; Villanueva-Meyer JE; Winkler E; de Groot J
Curr Neurol Neurosci Rep; 2024 May; 24(5):123-139. PubMed ID: 38578405
[TBL] [Abstract][Full Text] [Related]
34. Exosomes: Promising Delivery Tools for Overcoming Blood-Brain Barrier and Glioblastoma Therapy.
Khatami SH; Karami N; Taheri-Anganeh M; Taghvimi S; Tondro G; Khorsand M; Soltani Fard E; Sedighimehr N; Kazemi M; Rahimi Jaberi K; Moradi M; Nafisi Fard P; Darvishi MH; Movahedpour A
Mol Neurobiol; 2023 Aug; 60(8):4659-4678. PubMed ID: 37138197
[TBL] [Abstract][Full Text] [Related]
35. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.
Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T
Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491
[TBL] [Abstract][Full Text] [Related]
36. A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.
Barua NU; Hopkins K; Woolley M; O'Sullivan S; Harrison R; Edwards RJ; Bienemann AS; Wyatt MJ; Arshad A; Gill SS
Drug Deliv; 2016; 23(1):167-73. PubMed ID: 24786643
[TBL] [Abstract][Full Text] [Related]
37. Overcoming brain barriers through surface-functionalized liposomes for glioblastoma therapy; current status, challenges and future perspective.
Dong C; Yu X; Jin K; Qian J
Nanomedicine (Lond); 2023 Dec; 18(30):2161-2184. PubMed ID: 38180008
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in brain tumor therapy: application of electrospun nanofibers.
Norouzi M
Drug Discov Today; 2018 Apr; 23(4):912-919. PubMed ID: 29499377
[TBL] [Abstract][Full Text] [Related]
39. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
40. Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.
Haumann R; Videira JC; Kaspers GJL; van Vuurden DG; Hulleman E
CNS Drugs; 2020 Nov; 34(11):1121-1131. PubMed ID: 32965590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]